Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05495087 · ClinicalTrials.gov registry record · NA
IHT for Mild Cognitive Impairment
A NA study, sponsored by University of North Texas Health Science Center.
- Recruiting
- Registry status
- NA
- Development phase
- 66
- Enrollment target
NCT05495087: Recruiting NA study, sponsored by University of North Texas Health Science Center.
NCT05495087 is a NA study that is actively recruiting participants, run by University of North Texas Health Science Center. The registered enrollment target is 66 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05495087, a NA study, is actively recruiting participants, sponsored by University of North Texas Health Science Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 66 participants
- Enrollment target
Study Summary
This phase I clinical trial will examine the safety and efficacy of intermittent hypoxia training (IHT) for up to 12 weeks to treat subjects with mild cognitive impairment (MCI).
Primary Outcome
Change in scores or points (from 0 to 30) in Mini-mental State Examination. Higher scores indicate better testing performance or function.
Interventions
- DEVICE IHT Treatment
- OTHER Sham-IHT Control
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66 participants |
| Start Date | 2023-02-27 |
| Est. Completion | 2026-04-30 |
| Phase | NA |
What NCT05495087 shows while recruiting
NCT05495087 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 66 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 2 interventions - of which IHT Treatment is the first listed.
NCT05495087 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05495087 about?
NCT05495087 is a clinical study titled "IHT for Mild Cognitive Impairment". This phase I clinical trial will examine the safety and efficacy of intermittent hypoxia training (IHT) for up to 12 weeks to treat subjects with mild cognitive impairment (MCI).
What is the current status of trial NCT05495087?
This trial is currently recruiting. It is a NA study. The enrollment target is 66 participants. The study started on 2023-02-27. Estimated completion is 2026-04-30.
What interventions are being tested in trial NCT05495087?
The interventions under investigation include: IHT Treatment (DEVICE), Sham-IHT Control (OTHER).
Who is sponsoring clinical trial NCT05495087?
This trial is sponsored by University of North Texas Health Science Center, which has 21 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05495087's enrollment target sits among peer trials
66 1139th of 2000 higher than 857 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02584244 · 66 participants · Phase 1
Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers
- NCT03067051 · 66 participants · Phase 1
Clinical Study to Assess the Safety and Efficacy of the SpectraCure P18 System
- NCT03754725 · 66 participants · Phase 1
Ferritin and Iron Burden in SAH sIRB
- NCT03875378 · 66 participants · Phase 2
Transdermal Estrogen in Women With Anorexia Nervosa
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI